Insider Selling: Pediatrix Medical Group (NYSE:MD) Director Sells 10,478 Shares of Stock

Pediatrix Medical Group, Inc. (NYSE:MD) Director Michael Rucker sold 10,478 shares of the firm’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $23.00, for a total value of $240,994.00. Following the transaction, the director directly owned 59,101 shares of the company’s stock, valued at $1,359,323. This represents a 15.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Pediatrix Medical Group Price Performance

Pediatrix Medical Group stock traded down $0.06 during midday trading on Wednesday, hitting $22.91. The company’s stock had a trading volume of 840,843 shares, compared to its average volume of 783,477. Pediatrix Medical Group, Inc. has a 12 month low of $11.84 and a 12 month high of $23.43. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.97 billion, a PE ratio of 17.76 and a beta of 1.20. The stock’s 50-day moving average price is $18.11 and its 200-day moving average price is $15.66.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.21. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company had revenue of $492.88 million during the quarter, compared to analyst estimates of $476.45 million. During the same quarter last year, the firm posted $0.44 EPS. The business’s revenue for the quarter was down 3.6% on a year-over-year basis. Analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on MD shares. Wall Street Zen raised Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 4th. Zacks Research cut Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 7th. Truist Financial boosted their target price on Pediatrix Medical Group from $17.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, November 10th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Thursday, November 13th. Finally, Leerink Partners lifted their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Pediatrix Medical Group presently has a consensus rating of “Hold” and an average price target of $21.00.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds have recently modified their holdings of the business. Marshall & Sullivan Inc. WA purchased a new position in shares of Pediatrix Medical Group during the second quarter valued at $41,000. Canada Pension Plan Investment Board acquired a new stake in Pediatrix Medical Group during the 2nd quarter worth about $83,000. AlphaQuest LLC boosted its position in Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock worth $85,000 after acquiring an additional 811 shares during the period. Quantbot Technologies LP purchased a new position in Pediatrix Medical Group during the 2nd quarter valued at about $99,000. Finally, Smartleaf Asset Management LLC grew its stake in Pediatrix Medical Group by 10.6% during the 3rd quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock valued at $101,000 after acquiring an additional 601 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.